# Population Pharmacokinetics of Prolonged Infusion Meropenem in Cystic Fibrosis (CF) Children

> **NCT01429259** · PHASE4 · COMPLETED · sponsor: **Joseph Kuti** · enrollment: 30 (actual)

## Conditions studied

- Cystic Fibrosis
- Pneumonia
- Pseudomonas Aeruginosa Infection

## Interventions

- **DRUG:** meropenem

## Key facts

- **NCT ID:** NCT01429259
- **Lead sponsor:** Joseph Kuti
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-03-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01429259

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01429259, "Population Pharmacokinetics of Prolonged Infusion Meropenem in Cystic Fibrosis (CF) Children". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01429259. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*